Evidence map›Paper›PMID 11560989›Full record

ArticleThe Journal of experimental medicine2001

Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor.

S Mirshahidi, C T Huang, S Sadegh-Nasseri

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Frontiers in immunology · 2020
    Article
  12. Stories From the Dendritic Cell Guardhouse.Frontiers in immunology · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Manipulating antigenic ligand strength to selectively target myelin-reactive CD4+ T cells in EAE.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

S MirshahidiDepartment of Pathology, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
C T Huang
S Sadegh-Nasseri
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

NIGMS NIH HHS R01GM5354
6 · The paper itself

Abstract

Induction of tolerance in self-reactive memory T cells is an important process in the prevention of autoimmune responses against peripheral self-antigens in autoimmune diseases. Although naive T cells can readily be tolerized, memory T cells are less susceptible to tolerance induction. Recently, we demonstrated that low avidity engagement of T cell receptor (TCR) by low densities of agonist peptides induced anergy in T cell clones. Since memory T cells are more responsive to lower antigenic stimulation, we hypothesized that a low avidity TCR engagement may induce tolerance in memory T cells. We have explored two antigenic systems in two transgenic mouse models, and have tracked specific T cells that are primed and show memory phenotype. We demonstrate that memory CD4(+) T cells can be rendered anergic by presentation of low densities of agonist peptide-major histocompatibility complex complexes in vivo. We rule out other commonly accepted mechanisms for induction of T cell tolerance in vivo, such as deletion, ignorance, or immunosuppression. Anergy is the most likely mechanism because addition of interleukin 2-reversed anergy in specific T cells. Moreover, cytotoxic T lymphocyte antigen (CTLA)-4 plays a critical role in the induction of anergy because we observed that there was increased surface expression of CTLA-4 on anergized T cells, and that injection of anti-CTLA-4 blocking antibody restored anergy in vivo.

Indexed as

ImmunoconjugatesAbataceptAnimalsAntigens, CDAntigens, DifferentiationCD4-Positive T-LymphocytesClonal AnergyClonal DeletionCTLA-4 AntigenHemagglutinin Glycoproteins, Influenza VirusHemagglutinins, ViralHLA-DR1 AntigenImmunologic MemoryImmunophenotypingLeukocytes, MononuclearMiceAbataceptAntigens, CDAntigens, DifferentiationCTLA-4 AntigenCtla4 protein, mouseHemagglutinin Glycoproteins, Influenza VirusHemagglutinins, ViralHLA-DR1 AntigenImmunoconjugatesinfluenza hemagglutinin (306-318)Peptide FragmentsPeptidesReceptors, Antigen, T-CellTuberculin

Identifiers

PMID11560989
PMCPMC2195956
OpenAlexW2172144268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.